Polfa Tarchomin S.A.
Krzysztof Cabaj currently serves as CIO at Polfa Tarchomin S.A. since October 2020 and has held various titles including Kierownik Rozwoju Informatyki and Project Manager at the Strategic Project Management Office. As the CEO of CHR IT since March 2010, Krzysztof Cabaj focuses on project management, including EU grants, business intelligence, and IT management. Additional experience includes a role as Brand Representative at Nu Skin, Software Development Consultant at BEC, and CIO and Vice President at GET IT Language Solutions. Former positions include leadership roles in IT at PHOENIX Pharma Polska, ORFE S.A, and Budimex, with programming experience at ZUS. Krzysztof Cabaj holds degrees from Uniwersytet Przyrodniczo-Humanistyczny w Siedlcach and Bialystok University of Technology.
This person is not in any teams
Polfa Tarchomin S.A.
Polfa Tarchomin S.A. in Warsaw is one of the largest generic companies operating in Poland and one of the oldest pharmaceutical producers in the world. The company history dates back to 1823 and the production of the first medicinal preparations. Polfa Tarchomin SA is a leader in the anti-infectives market. The company also holds an significant market position in the category of insulin, psychotropic drugs and dermatological preparations. Polfa Tarchomin S.A in total provides over a hundred medicinal products. All of them are available in a range of forms and sizes in order to ensure optimal medical treatment and minimal side effects experienced by the patient. Polfa Tarchomin S.A. specialises in the prescription drugs. Over the counter medicines constitute a supplement to the main product range. Our medicines are produced in buildings and facilities which meet strict global requirements and quality standards. The quality of our products has been confirmed by the obtained GMP certificates. Currently the company has 40 production lines and installations which produce drugs in pharmaceutical forms including gels, aerosols, tablets, coated tablets, capsules, ampoules, vials and insulin cartridges. The production line of oral penicillin forms, aerosol filling and freeze-drying techniques distinguish the company among other manufacturers in the industry.